查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762471

全球富血小板血漿（PRP）市場：市場規模、佔有率、趨勢、產業分析（依類型、應用、最終用途和地區）、未來預測（2025-2034）

Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 113 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到2034年，全球富血小板血漿（PRP）市場規模將達到 28.5798億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

富血小板血漿（PRP）是再生醫學和治療領域的關鍵組成部分，徹底改變了組織修復和癒合的方法。 PRP 源自於患者自身血液，與傳統療法相比具有許多優勢，包括降低過敏反應風險和加速復原時間。 PRP 的安全性、有效性和天然癒合特性推動了其需求的成長，使其成為骨科、皮膚科、運動醫學和醫學美容領域越來越受歡迎的選擇。

由於科學的持續進步和臨床需求的不斷成長，PRP 市場迅速擴張。全球各國政府正透過資金、研究經費和優惠法規支持再生醫學，鼓勵基於 PRP 的療法的開發和應用。這些因素加速 PRP 療法在組織修復和肌肉骨骼癒合等領域的應用。此外，骨關節炎、肌腱損傷和脫髮等慢性疾病的盛行率不斷上升，這些疾病通常與人口老化和生活方式的改變有關，這進一步刺激了對 PRP 的需求。 PRP 能夠進一步促進組織再生和癒合，使其成為臨床和美容應用中的寶貴工具。

整形外科醫生和皮膚科醫生日益採用 PRP 療法來增強皮膚體積、膚色和質地，這是市場成長的主要推動因素。美國整形外科醫師協會報告指出，作為2023年最熱門的微創手術，光在美國就有約 590萬例重建手術。

富血小板血漿市場：分析概論

依類型，純富血小板血漿（P-PRP）或無白血球富血小板血漿在2024年佔據了富血小板血漿市場佔有率的主導地位。這得益於其獨特的優勢，即最大限度地降低風險和副作用，並減少治療期間與過敏和免疫反應相關的擔憂。

依應用，皮膚科領域在2024年佔據了最大的佔有率。這種快速成長是由對非手術美容程序（例如皮膚年輕化、痤瘡疤痕治療和頭髮再生）日益成長的需求所推動的。人們對美容療程的認識不斷提高，以及 PRP 在改善皮膚紋理和促進頭髮生長方面的日益普及，對這一成長做出了重大貢獻。皮膚科醫生使用 PRP 來治療各種皮膚疾病，擴大了他們的治療選擇。

2024年，北美佔據了全球富血小板血漿市場的收入佔有率。該市場的主要驅動力包括不斷成長的整容手術需求、骨科手術的普及以及運動相關損傷發生率的上升。此外，微針療法除了最初的皮膚嫩膚應用外，還因其透皮給藥等各種應用而日益普及。

由於PRP療法在肌肉骨骼損傷治療中的廣泛應用，歐洲富血小板血漿市場經歷顯著成長。跟腱病、足底筋膜炎和網球肘等疾病的流行尤其助長了這一成長趨勢。

全球主要參與者包括Vivostat、Arthrex Inc.、RegenOrthoSport和Dr. PRP USA LLC、Juventix Regenerative Medical, LLC、Terumo Cardiovascular Systems Corporation、Zimmer Biomet、Isto Biologics、Apex Biologix、Regen Lab SA。

目錄

第1章 簡介

第2章 執行摘要

第3章 分析方法

第4章 市場洞察

  • 富血小板血漿（PRP）：產業概覽
  • 價值鏈分析
    • 富血小板血漿（PRP）市場動態
    • 驅動因素和機會
      • 美容外科和皮膚科對 PRP 的需求不斷成長
      • 老年人口的增加、非骨科和運動傷害發生率的上升將在預測期內加速對 PRP 的需求
    • 限制因素和挑戰
      • 高成本PRP 療法及償付政策 缺乏政策可能會阻礙市場成長
  • 波特五力分析
    • 替代品威脅：（低至中）
    • 新進入者威脅：（中至高）
    • 買方議價能力：（低至中）
    • 供應商議價能力：（中至高）
    • 競爭敵對：（中至高）
  • PESTLE 分析
  • COVID-19 影響分析及產業趨勢

第5章 富血小板血漿市場評估（依類型）

  • 關鍵分析結果
  • 純富血小板血漿（P-PRP）
  • L-PRP 血漿
  • 純富血小板纖維蛋白（P-PRF）
  • L-PRF 纖維蛋白

第6章 富血小板血漿（PRP）市場應用評估

  • 簡介
  • 骨科
  • 運動醫學
  • 一般外科
  • 皮膚科
  • 眼科
  • 神經科
  • 心臟科
  • 其他

第7章 富血小板血漿（PRP）市場最終用途評估

  • 簡介
  • 醫院
  • 診所
  • 其他

第8章 富血小板血漿（PRP）市場各地區評估

  • 簡介
  • 北美美洲
    • 北美富血小板血漿（PRP）市場（依類型）
    • 北美富血小板血漿（PRP）市場（依應用）
    • 依最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲富血小板血漿（PRP）市場（依類型）
    • 歐洲富血小板血漿（PRP）市場（依應用）
    • 依最終用途
    • 法國
    • 德國
    • 英國
    • 義大利
    • 荷蘭
    • 西班牙
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 亞太地區富血小板血漿（PRP）市場（依類型）
    • 亞太地區富血小板血漿（PRP）市場（依應用）
    • 依最終用途應用
    • 日本
    • 中國
    • 印度
    • 馬來西亞
    • 印尼
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 拉丁美洲
    • 拉丁美洲富血小板血漿（PRP）市場（依類型）
    • 拉丁美洲富血小板血漿（PRP）市場（依應用）
    • 依最終用途
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 中東和非洲富血小板血漿（PRP）市場（依類型）
    • 中東和非洲富血小板血漿（PRP）市場（依應用）
    • 依最終用途
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區非洲

第9章 競爭格局

  • 市場參與者：分類
  • 戰略框架
  • 供應商格局
  • 戰略分類
    • 上市/核准/開發

第10章 公司簡介

  • Vivostat
  • Arthrex, Inc.
  • RegenOrthoSport
  • Dr PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Cardiovascular Systems Corporation
  • Zimmer Biomet
  • Isto Biologics
  • APEX Biologix
  • Regen Lab SA
Product Code: PM5030

The global platelet rich plasma (PRP) market size is expected to reach USD 2,857.98 million by 2034, according to a new study by Polaris Market Research. The report "Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Platelet rich plasma (PRP) is a key component in the field of regenerative medicine and therapeutic treatments, significantly transforming approaches in tissue repair and healing. Derived from a patient's own blood, PRP offers several advantages over conventional treatment methods, such as reduced risk of allergic reactions and faster recovery times. The growing demand for PRP is fueled by its safety, effectiveness, and natural healing properties, making it an increasingly preferred option across orthopedics, dermatology, sports medicine, and medical aesthetic procedures.

The PRP market is expanding rapidly due to ongoing scientific advancements and increasing demand in real world clinical settings. Government worldwide is supporting regenerative medicine through funding, research grants, and favorable regulations which is encouraging the development and adoption of PRP based treatments. Therefore, these factors have accelerated the usage of PRP therapies in areas such as tissue repair and musculoskeletal healing. Additionally, the growing prevalence of chronic conditions such as osteoarthritis, tendon injuries, and hair loss, which are often linked to aging populations and lifestyle changes, is further fueling demand for PRP. PRP further promotes tissue regeneration and healing, making it a valuable tool in both clinical and cosmetic applications.

The growing adoption of PRP treatments by plastic surgeons and dermatologists to enhance skin volume, tone, and texture has contributed significantly to the growth of the market. As the top minimally invasive procedure of 2023, the American Society of Plastic Surgeons reported nearly 5.9 million reconstructive procedures in the US alone.

Platelet Rich Plasma Market Report Highlights

Based on type, the pure platelet-rich plasma (P-PRP) or leukocyte-poor platelet-rich plasma segment dominated the platelet rich plasma market share in 2024, due to its distinct advantage with minimal risk and adverse effects, reducing concerns related to allergies and immune responses during treatments.

By application, the dermatology segment accounted for the largest share in 2024. The rapid growth is attributed to the growing demand for nonsurgical cosmetic surgery, such as skin rejuvenation, acne scar treatment, and hair restoration. Increased awareness of aesthetic treatments and the rising popularity of PRP for improving skin texture and hair growth significantly contributed to this growth. Dermatologists are using PRP to address diverse skin conditions, expanding treatment options.

North America dominated the global platelet rich plasma market revenue share in 2024. This market is primarily driven by increasing demand for cosmetic surgeries, a high prevalence of orthopedic procedures, and a rising incidence of sports-related injuries. Furthermore, micro-needling is gaining popularity for various applications, including transcutaneous drug administration, in addition to its original intended use for skin rejuvenation.

The platelet rich plasma market in Europe is experiencing significant growth, owing to the widespread adoption of PRP therapy for the treatment of musculoskeletal injuries. Conditions such as Achilles tendinopathy, plantar fasciitis, and tennis elbow are particularly contributing to this upward trend.

A few global key market players are Vivostat; Arthrex Inc.; RegenOrthoSport; Dr. PRP USA LLC; Juventix Regenerative Medical, LLC; Terumo Cardiovascular Systems Corporation; Zimmer Biomet; Isto Biologics; Apex Biologix; and Regen Lab SA.

Polaris Market Research has segmented the platelet rich plasma market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Pure Platelet-Rich Plasma (P-PRP)

Leukocyte-and Platelet-Rich Plasma (L-PRP)

Pure Platelet-Rich Fibrin (P-PRF) - or Leukocyte-Poor Platelet-Rich Fibrin

Leukocyte- and Platelet-Rich Fibrin (L-PRF)

By Application Outlook (Revenue, USD Million, 2020-2034)

Orthopedics

Sports Medicine

General Surgery

Dermatology

Ophthalmology

Neurology

Cardiology

Others

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Clinics

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Malaysia

Australia

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objective of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Research Methodology

  • 2.1 Research Methodology
  • 2.2 Research Scope and Assumptions
  • 2.3 Information Procurement
    • 2.3.1 Purchased Database
    • 2.3.2 Internal Database
    • 2.3.3 Secondary Sources
    • 2.3.4 Third Party Perspective
    • 2.3.5 Primary Research
  • 2.4 Information Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation and Data Visualization
  • 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

  • 4.1 Platelet Rich Plasma (PRP) - Industry snapshot
  • 4.2 Platelet Rich Plasma (PRP) Market - Value Chain Analysis
    • 4.2.1 Platelet Rich Plasma (PRP) Market Dynamics
    • 4.2.2 Drivers and Opportunities
      • 4.2.2.1 Rise in demand of PRP in cosmetic surgeries and dermatology
      • 4.2.2.2 Increasing geriatric population, and rise in the occurrence of orthopaedic and sports injuries accelerate the PRP demand over the forecast period
    • 4.2.3 Restraints and Challenges
      • 4.2.3.1 High cost of PRP therapy and lack of reimbursement policy may hamper the market growth
  • 4.3 Platelet Rich Plasma (PRP) Market - Porter's Five Forces
    • 4.3.1 Threat of Substitutes: (Low to Moderate)
    • 4.3.2 Threat of New Entrants: (Moderate to high)
    • 4.3.3 Bargaining power of buyers: (Low to Moderate)
    • 4.3.4 Bargaining power of suppliers: (Moderate to High)
    • 4.3.5 Competitive Rivalry: (Moderate to High)
  • 4.4 Platelet Rich Plasma (PRP) Market - PESTLE Analysis
  • 4.5 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Platelet Rich Plasma (PRP) Market Assessment by Type

  • 5.1 Introduction
  • 5.2 Pure Platelet-Rich Plasma (P-PRP)
  • 5.3 Leukocyte-and Platelet-Rich Plasma (L-PRP)
  • 5.4 Pure Platelet-Rich Fibrin (P-PRF)
  • 5.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)

Chapter 6. Platelet Rich Plasma (PRP) Market Assessment by Application

  • 6.1 Introduction
  • 6.2 Orthopedics
  • 6.3 Sports Medicine
  • 6.4 General Surgery
  • 6.5 Dermatology
  • 6.6 Ophthalmology
  • 6.7 Neurology
  • 6.8 Cardiology
  • 6.9 Others

Chapter 7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Others

Chapter 8. Platelet Rich Plasma (PRP) Market Assessment by Region

  • 8.1 Introduction
  • 8.2 Platelet Rich Plasma (PRP) Market - North America
    • 8.2.1 North America Platelet Rich Plasma (PRP), By Type
    • 8.2.2 North America Platelet Rich Plasma (PRP), By Application
    • 8.2.3 North America Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.2.4 Platelet Rich Plasma (PRP) Market - U.S.
      • 8.2.4.1 U.S. Platelet Rich Plasma (PRP), By Type
      • 8.2.4.2 U.S. Platelet Rich Plasma (PRP), By Application
      • 8.2.4.3 U.S. Platelet Rich Plasma (PRP), By End-Use
    • 8.2.5 Platelet Rich Plasma (PRP) Market - Canada
      • 8.2.5.1 Canada Platelet Rich Plasma (PRP), By Type
      • 8.2.5.2 Canada Platelet Rich Plasma (PRP), By Application
      • 8.2.5.3 Canada Platelet Rich Plasma (PRP), By End-Use
  • 8.3 Platelet Rich Plasma (PRP) Market - Europe
    • 8.3.1 Europe Platelet Rich Plasma (PRP), By Type
    • 8.3.2 Europe Platelet Rich Plasma (PRP), By Application
    • 8.3.3 Europe Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.3.4 Platelet Rich Plasma (PRP) Market - France
      • 8.3.4.1 France Platelet Rich Plasma (PRP), By Type
      • 8.3.4.2 France Platelet Rich Plasma (PRP), By Application
      • 8.3.4.3 France Platelet Rich Plasma (PRP), By End-Use
    • 8.3.5 Platelet Rich Plasma (PRP) Market - Germany
      • 8.3.5.1 Germany Platelet Rich Plasma (PRP), By Type
      • 8.3.5.2 Germany Platelet Rich Plasma (PRP), By Application
      • 8.3.5.3 Germany Platelet Rich Plasma (PRP), By End-Use
    • 8.3.6 Platelet Rich Plasma (PRP) Market - UK
      • 8.3.6.1 UK Platelet Rich Plasma (PRP), By Type
      • 8.3.6.2 UK Platelet Rich Plasma (PRP), By Application
      • 8.3.6.3 UK Platelet Rich Plasma (PRP), By End-Use
    • 8.3.7 Platelet Rich Plasma (PRP) Market - Italy
      • 8.3.7.1 Italy Platelet Rich Plasma (PRP), By Type
      • 8.3.7.2 Italy Platelet Rich Plasma (PRP), By Application
      • 8.3.7.3 Italy Platelet Rich Plasma (PRP), By End-Use
    • 8.3.8 Platelet Rich Plasma (PRP) Market - Netherlands
      • 8.3.8.1 Netherlands Platelet Rich Plasma (PRP), By Type
      • 8.3.8.2 Netherlands Platelet Rich Plasma (PRP), By Application
      • 8.3.8.3 Netherlands Platelet Rich Plasma (PRP), By End-Use
    • 8.3.9 Platelet Rich Plasma (PRP) Market - Spain
      • 8.3.9.1 Spain Platelet Rich Plasma (PRP), By Type
      • 8.3.9.2 Spain Platelet Rich Plasma (PRP), By Application
      • 8.3.9.3 Spain Platelet Rich Plasma (PRP), By End-Use
    • 8.3.10 Platelet Rich Plasma (PRP) Market - Russia
      • 8.3.10.1 Russia Platelet Rich Plasma (PRP), By Type
      • 8.3.10.2 Russia Platelet Rich Plasma (PRP), By Application
      • 8.3.10.3 Russia Platelet Rich Plasma (PRP), By End-Use
    • 8.3.11 Platelet Rich Plasma (PRP) Market - Rest of Europe
      • 8.3.11.1 Rest of Europe Platelet Rich Plasma (PRP), By Type
      • 8.3.11.2 Rest of Europe Platelet Rich Plasma (PRP), By Application
      • 8.3.11.3 Rest of Europe Platelet Rich Plasma (PRP), By End-Use
  • 8.4 Platelet Rich Plasma (PRP) Market - Asia Pacific
    • 8.4.1 Asia Pacific Platelet Rich Plasma (PRP), By Type
    • 8.4.2 Asia Pacific Platelet Rich Plasma (PRP), By Application
    • 8.4.3 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.4.4 Platelet Rich Plasma (PRP) Market - Japan
      • 8.4.4.1 Japan Platelet Rich Plasma (PRP), By Type
      • 8.4.4.2 Japan Platelet Rich Plasma (PRP), By Application
      • 8.4.4.3 Japan Platelet Rich Plasma (PRP), By End-Use
    • 8.4.5 Platelet Rich Plasma (PRP) Market - China
      • 8.4.5.1 China Platelet Rich Plasma (PRP), By Type
      • 8.4.5.2 China Platelet Rich Plasma (PRP), By Application
      • 8.4.5.3 China Platelet Rich Plasma (PRP), By End-Use
    • 8.4.6 Platelet Rich Plasma (PRP) Market - India
      • 8.4.6.1 India Platelet Rich Plasma (PRP), By Type
      • 8.4.6.2 India Platelet Rich Plasma (PRP), By Application
      • 8.4.6.3 India Platelet Rich Plasma (PRP), By End-Use
    • 8.4.7 Platelet Rich Plasma (PRP) Market - Malaysia
      • 8.4.7.1 Malaysia Platelet Rich Plasma (PRP), By Type
      • 8.4.7.2 Malaysia Platelet Rich Plasma (PRP), By Application
      • 8.4.7.3 Malaysia Platelet Rich Plasma (PRP), By End-Use
    • 8.4.8 Platelet Rich Plasma (PRP) Market - Indonesia
      • 8.4.8.1 Indonesia Platelet Rich Plasma (PRP), By Type
      • 8.4.8.2 Indonesia Platelet Rich Plasma (PRP), By Application
      • 8.4.8.3 Indonesia Platelet Rich Plasma (PRP), By End-Use
    • 8.4.9 Platelet Rich Plasma (PRP) Market - South Korea
      • 8.4.9.1 South Korea Platelet Rich Plasma (PRP), By Type
      • 8.4.9.2 South Korea Platelet Rich Plasma (PRP), By Application
      • 8.4.9.3 South Korea Platelet Rich Plasma (PRP), By End-Use
    • 8.4.10 Platelet Rich Plasma (PRP) Market - Australia
      • 8.4.10.1 Australia Platelet Rich Plasma (PRP), By Type
      • 8.4.10.2 Australia Platelet Rich Plasma (PRP), By Application
      • 8.4.10.3 Australia Platelet Rich Plasma (PRP), By End-Use
    • 8.4.11 Platelet Rich Plasma (PRP) Market - Rest of APAC
      • 8.4.11.1 Rest of APAC Platelet Rich Plasma (PRP), By Type
      • 8.4.11.2 Rest of APAC Platelet Rich Plasma (PRP), By Application
      • 8.4.11.3 Rest of APAC Platelet Rich Plasma (PRP), By End-Use
  • 8.5 Platelet Rich Plasma (PRP) Market - Latin America
    • 8.5.1 Latin America Platelet Rich Plasma (PRP), By Type
    • 8.5.2 Latin America Platelet Rich Plasma (PRP), By Application
    • 8.5.3 Latin America Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.5.4 Platelet Rich Plasma (PRP) Market - Mexico
      • 8.5.4.1 Mexico Platelet Rich Plasma (PRP), By Type
      • 8.5.4.2 Mexico Platelet Rich Plasma (PRP), By Application
      • 8.5.4.3 Mexico Platelet Rich Plasma (PRP), By End-Use
    • 8.5.5 Platelet Rich Plasma (PRP) Market - Brazil
      • 8.5.5.1 Brazil Platelet Rich Plasma (PRP), By Type
      • 8.5.5.2 Brazil Platelet Rich Plasma (PRP), By Application
      • 8.5.5.3 Brazil Platelet Rich Plasma (PRP), By End-Use
    • 8.5.6 Platelet Rich Plasma (PRP) Market - Argentina
      • 8.5.6.1 Argentina Platelet Rich Plasma (PRP), By Type
      • 8.5.6.2 Argentina Platelet Rich Plasma (PRP), By Application
      • 8.5.6.3 Argentina Platelet Rich Plasma (PRP), By End-Use
    • 8.5.7 Platelet Rich Plasma (PRP) Market - Rest of Latin America
      • 8.5.7.1 Rest of LATAM Platelet Rich Plasma (PRP), By Type
      • 8.5.7.2 Rest of LATAM Platelet Rich Plasma (PRP), By Application
      • 8.5.7.3 Rest of LATAM Platelet Rich Plasma (PRP), By End-Use
  • 8.6 Platelet Rich Plasma (PRP) Market - Middle East Africa
    • 8.6.1 Middle East & Africa Platelet Rich Plasma (PRP), By Type
    • 8.6.2 Middle East & Africa Platelet Rich Plasma (PRP), By Application
    • 8.6.3 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use
    • 8.6.4 Platelet Rich Plasma (PRP) Market - Saudi Arabia
      • 8.6.4.1 Saudi Arabia Platelet Rich Plasma (PRP), By Type
      • 8.6.4.2 Saudi Arabia Platelet Rich Plasma (PRP), By Application
      • 8.6.4.3 Saudi Arabia Platelet Rich Plasma (PRP), By End-Use
    • 8.6.5 Platelet Rich Plasma (PRP) Market - South Africa
      • 8.6.5.1 South Africa Platelet Rich Plasma (PRP), By Type
      • 8.6.5.2 South Africa Platelet Rich Plasma (PRP), By Application
      • 8.6.5.3 South Africa Platelet Rich Plasma (PRP), By End-Use
    • 8.6.6 Platelet Rich Plasma (PRP) Market - Rest of MEA
      • 8.6.6.1 Rest of MEA Platelet Rich Plasma (PRP), By Type
      • 8.6.6.2 Rest of MEA Platelet Rich Plasma (PRP), By Application
      • 8.6.6.3 Rest of MEA Platelet Rich Plasma (PRP), By End-Use

Chapter 9. Competitive Landscape

  • 9.1 Key Market Players: Categorization
  • 9.2 Strategy Framework
  • 9.3 Vendor Landscape
  • 9.4 Strategies Categorization
    • 9.4.1 Launch/Approval/Development

Chapter 10. Company Profiles

  • 10.1 Vivostat
    • 10.1.1 Business Overview
    • 10.1.2 Products and Services
  • 10.2 Arthrex, Inc.
    • 10.2.1 Business Overview
    • 10.2.2 Products and Services
    • 10.2.3 Recent Developments
  • 10.3 RegenOrthoSport
    • 10.3.1 Business Overview
    • 10.3.2 Products and Services
  • 10.4 Dr PRP USA LLC
    • 10.4.1 Business Overview
    • 10.4.2 Products and Services
  • 10.5 Juventix Regenerative Medical, LLC.
    • 10.5.1 Business Overview
    • 10.5.2 Products and Services
  • 10.6 Terumo Cardiovascular Systems Corporation
    • 10.6.1 Business Overview
    • 10.6.2 Financial Snapshot
      • 10.6.2.1 Revenue by Geographic Region
    • 10.6.3 Products and Services
  • 10.7 Zimmer Biomet
    • 10.7.1 Business Overview
    • 10.7.2 Financial Snapshot
      • 10.7.2.1 Net Sales by Geographic
      • 10.7.2.2 Net Sales by Product Category
    • 10.7.3 Products and Services
    • 10.7.4 Recent Developments
  • 10.8 Isto Biologics
    • 10.8.1 Business Overview
    • 10.8.2 Products and Services
    • 10.8.3 Recent Developments
  • 10.9 APEX Biologix
    • 10.9.1 Business Overview
    • 10.9.2 Products and Services
    • 10.9.3 Recent Developments
  • 10.10 Regen Lab SA
    • 10.10.1 Business Overview
    • 10.10.2 Products and Services

List of Tables

  • Table 1 Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 2 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Plasma (P-PRP), 2021 - 2034 (USD Million)
  • Table 3 Platelet Rich Plasma (PRP) Market, By Leukocyte-and Platelet-Rich Plasma (L-PRP), 2021 - 2034 (USD Million)
  • Table 4 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Fibrin (P-PRF), 2021 - 2034 (USD Million)
  • Table 5 Platelet Rich Plasma (PRP) Market, By Leukocyte- and Platelet-Rich Fibrin (L-PRF), 2021 - 2034 (USD Million)
  • Table 6 Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 7 Platelet Rich Plasma (PRP) Market, By Orthopedics, 2021 - 2034 (USD Million)
  • Table 8 Platelet Rich Plasma (PRP) Market, By Sports Medicine, 2021 - 2034 (USD Million)
  • Table 9 Platelet Rich Plasma (PRP) Market, By General Surgery, 2021 - 2034 (USD Million)
  • Table 10 Platelet Rich Plasma (PRP) Market, By Dermatology, 2021 - 2034 (USD Million)
  • Table 11 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2021 - 2034 (USD Million)
  • Table 12 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2021 - 2034 (USD Million)
  • Table 13 Platelet Rich Plasma (PRP) Market, By Cardiology, 2021 - 2034 (USD Million)
  • Table 14 Platelet Rich Plasma (PRP) Market, By Others, 2021 - 2034 (USD Million)
  • Table 15 Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 16 Platelet Rich Plasma (PRP) Market, By Hospitals, 2021 - 2034 (USD Million)
  • Table 17 Platelet Rich Plasma (PRP) Market, By Clinics, 2021 - 2034 (USD Million)
  • Table 18 Platelet Rich Plasma (PRP) Market, By Others, 2021 - 2034 (USD Million)
  • Table 19 Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2021 - 2034 (USD Million)
  • Table 20 North America Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 21 North America Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 22 North America Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 23 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 24 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 25 U.S. Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 26 Canada Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 27 Canada Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 28 Canada Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 29 Europe Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 30 Europe Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 31 Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 32 France Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 33 France Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 34 France Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 35 Germany Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 36 Germany Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 37 Germany Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 38 UK Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 39 UK Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 40 UK Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 41 Italy Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 42 Italy Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 43 Italy Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 44 Netherlands Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 45 Netherlands Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 46 Netherlands Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 47 Spain Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 48 Spain Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 49 Spain Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 50 Russia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 51 Russia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 52 Russia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 53 Rest of Europe Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 54 Rest of Europe Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 55 Rest of Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 56 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 57 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 58 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 59 Japan Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 60 Japan Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 61 Japan Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 62 China Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 63 China Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 64 China Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 65 India Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 66 India Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 67 India Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 68 Malaysia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 69 Malaysia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 70 Malaysia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 71 Indonesia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 72 Indonesia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 73 Indonesia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 74 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 75 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 76 South Korea Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 77 Australia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 78 Australia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 79 Australia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 80 Rest of APAC Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 81 Rest of APAC Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 82 Rest of APAC Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 83 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 84 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 85 Latin America Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 86 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 87 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 88 Mexico Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 89 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 90 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 91 Brazil Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 92 Argentina Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 93 Argentina Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 94 Argentina Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 95 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 96 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 97 Rest of LATAM Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 98 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 99 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 100 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 101 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 102 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 103 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 104 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 105 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 106 South Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
  • Table 107 Rest of MEA Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
  • Table 108 Rest of MEA Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
  • Table 109 Rest of MEA Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)

List of Figures

  • Figure 1. Information Procurement
  • Figure 2. Primary Research Pattern
  • Figure 3. Primary research process
  • Figure 4. Market research approaches - Bottom-Up Approach
  • Figure 5. Market research approaches - Top-Down Approach
  • Figure 6. Market research approaches - Combined Approach
  • Figure 7. Executive Summary
  • Figure 8. Market by Region, 2022 (USD Million)
  • Figure 9. Platelet Rich Plasma (PRP) Market, 2021 - 2034 (USD Million)
  • Figure 10. Value Chain Analysis
  • Figure 11. Porter's Five Forces
  • Figure 12. PESTLE Analysis
  • Figure 13. Market by Type
  • Figure 14. Platelet Rich Plasma (PRP) Market, By Type, 2024 & 2034 (USD Million)
  • Figure 15. Market by Application
  • Figure 16. Platelet Rich Plasma (PRP) Market, By Application, 2024 & 2034 (USD Million)
  • Figure 17. Market by End-Use
  • Figure 18. Platelet Rich Plasma (PRP) Market, By End-Use, 2024 & 2034 (USD Million)
  • Figure 19. Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2024 & 2034 (USD Million)